1 In 3 of Your Patients Has Drug-Resistant Epilepsy¹

The rate of DRE has not been significantly reduced over the last 20 years despite the entry of new antiepileptic drugs (AEDs) with unique MOAs³

Drug-Resistant Epilepsy (DRE) is when a patient fails on 2 appropriately chosen and tolerated (whether as monotherapy or as combination) treatments.²

Epilepsy Population (seizure freedom rates)³

The cost of doing nothing can equal uncontrolled seizures and more.

Increased hospital stays

Increased mortality and morbidity including SUDEP

Seizure-related injuries

DRE requires a comprehensive treatment for a complex disease.

Treatment options and treatment goals^2,4,5

New strategies are needed to help patients with DRE, as simply extending the use of AEDs is not always appropriate.

References

1. Mohanraj R, et al. Eur J Neurol. 2006;13:277-282. 2. Kwan P, et al. Epilepsia. 2010;51(6):1069-1077. 3. Brodie MJ. Epilepsia. 2013;54:5-8. 4. Jobst B, Epilepsia, 209; 50(Suppl 8) 61-56 5. Kossoff et al, Epilepsia, 2007; 48; 77-81 6. Kwan P et al. Epilepsia. 2009; 57-62, 7. Gilliam. Neurology. 2002; S9-S19, 8. Faught et al. Epilepsia. 2009; 501-509